"Ovarian age-based" stimulation of young women with diminished ovarian reserve results in excellent pregnancy rates with in vitro fertilization

Fertility and Sterility

Volumn 86, Issue 6, 2006, Pages 1621-1625

  Gleicher, Norbert ^a   Barad, David ^a  

^a Chicago Center for Human Reproduction   (United States)

Author keywords

IVF; Ovarian resistance; ovarian stimulation; premature ovarian aging; premature ovarian failure

Indexed keywords

ADULT; AGE; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DIMINISHED OVARIAN RESERVE; FEMALE; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SCHOOL; OVARY; OVARY DISEASE; OVARY FUNCTION; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; STANDARDIZATION; TREATMENT OUTCOME;

ADULT; AGE FACTORS; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; TREATMENT OUTCOME;

EID: 33751163264     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.04.046     Document Type: Article

References (14)

1. de Boer E.J., den Tonkelaar I., te Velde E.R., Burger C.W., Klip H., and van Leeuwen F.E. A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril 77 (2002) 978-985
2. de Boer E.J., den Tonkelaar I., te Velde E.R., Burger C.W., Klip H., and van Leeuwen F.E. Increased risk of early menopause transition and natural menopause after poor response at first IVF treatment. Hum Reprod 18 (2003) 1544-1552
3. Nikolaou D., and Templeton A. Early ovarian aging: a hypothesis. Detection and clinical relevance. Hum Reprod 18 (2003) 1137-1139
4. Faddy M.J., Gosden R.G., Gougeon A., Richardson S.J., and Nelson J.F. Accelerated disappearance of ovarian follicules in mid-life; implications for forecasting menopause. Hum Reprod 7 (1992) 1342-1346
5. Gleicher N. Ovarian aging: is there a "norm"?. Contemp Ob Gyn 50 (2005) 65-75
6. Beckers N.G., Macklon N.S., Eijkemans M.J., and Fauser B.C. Women with regular menstrual cycles and poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging. Fertil Steril 78 (2002) 291-297
7. Van Hooff M.H., Alberda A.T., Huisman G.J., Zeilmaker G.H., and Leerentveld R.A. Doubling the human menopausal gonadotropin dose in the course of in vitro fertilization treatment cycles in low responders: a randomized study. Hum Reprod 8 (1993) 369-373
8. Karande V., and Gleicher N. A rational approach to management of low responders in in vitro fertilization. Hum Reprod 14 (1999) 1744-1748
9. Karande V., Rao R., Pratt D., Balin M., Levrant S., Morris R., et al. A randomized prospective comparison between intrauterine inseminations and fallopian tube perfusion for the treatment of infertility. Fertil Steril 64 (1995) 638-640
10. The European and Middle East Orgalutron Study Group. Comparable clinical outcome using GnRH antagonist ganirelix or a long protocol of the GnRH agonists triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 16 (2001) 644-651
11. Bancsi L.F., Broermans F.J., Mol B.W., Habbema J.D., and Tevelde E.R. Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta analysis. Fertil Steril 79 (2003) 1091-1100
12. Sallam H.N., Ezzeldin F., Agameya A.F., Rahman A.F., and El-Garem Y. Defining poor responders in assisted reproduction. Int J Fertil Womens Med 50 (2005) 115-120
13. Abdalla H., and Trum M.Y. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve. Hum Reprod 19 (2004) 893-898
14. Fasouliotis S.J., Simon A., and Laufer N. Evaluation and treatment of low responders in assisted reproductive technology. A challenge to meet. J Assist Reprod Genet 17 (2000) 357-373